GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
News Medical16m
Study uncovers molecular mechanisms behind insulin resistance in skeletal muscle
Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high ...
Cochrane22h
Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney disease and diabetes?
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Frontiers4h
Molecular and Genomics Approaches to Understanding Innate Immune Memory
Recent advances in the field of immunology suggest that innate immune cells (e.g. dendritic cells, NK cells, phagocytes) are capable of displaying a form of ...